HEXPOL AB ser. B
HEXPOL AB (publ) develops, manufactures, and sells various polymer compounds and engineered gaskets, seals, and wheels in Sweden, rest of Europe, the United States, rest of the Americas, and Asia. It operates through two segments, HEXPOL Compounding and HEXPOL Engineered Products. The HEXPOL Compounding segment develops and manufactures natural and synthetic rubber compounds under the HEXFLAME, H… Read more
HEXPOL AB ser. B (0R7O) - Net Assets
Latest net assets as of December 2021: Skr11.65 Billion SEK
Based on the latest financial reports, HEXPOL AB ser. B (0R7O) has net assets worth Skr11.65 Billion SEK as of December 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr17.96 Billion) and total liabilities (Skr6.31 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr11.65 Billion |
| % of Total Assets | 64.86% |
| Annual Growth Rate | 13.54% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 12.97 |
HEXPOL AB ser. B - Net Assets Trend (2017–2021)
This chart illustrates how HEXPOL AB ser. B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for HEXPOL AB ser. B (2017–2021)
The table below shows the annual net assets of HEXPOL AB ser. B from 2017 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | Skr11.65 Billion | +27.56% |
| 2020-12-31 | Skr9.13 Billion | -6.39% |
| 2019-12-31 | Skr9.76 Billion | +13.55% |
| 2018-12-31 | Skr8.59 Billion | +22.57% |
| 2017-12-31 | Skr7.01 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to HEXPOL AB ser. B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 54.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr9.41 Billion | 80.82% |
| Common Stock | Skr69.00 Million | 0.59% |
| Other Components | Skr2.17 Billion | 18.59% |
| Total Equity | Skr11.65 Billion | 100.00% |
HEXPOL AB ser. B Competitors by Market Cap
The table below lists competitors of HEXPOL AB ser. B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Inner Mongolia ERDOS Resources Co Ltd
SHG:600295
|
$1.64 Billion |
|
Primary Health Properties PLC
PINK:PHPRF
|
$1.64 Billion |
|
Greek Org of Football Prognostics
PINK:GOFPY
|
$1.64 Billion |
|
The Foschini Group Limited
PINK:FHNGY
|
$1.64 Billion |
|
Organon & Co
NYSE:OGN
|
$1.64 Billion |
|
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN
|
$1.64 Billion |
|
Forvia SE
PA:FRVIA
|
$1.64 Billion |
|
Red Cat Holdings Inc
NASDAQ:RCAT
|
$1.64 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HEXPOL AB ser. B's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 9,133,000,000 to 11,650,000,000, a change of 2,517,000,000 (27.6%).
- Net income of 2,358,000,000 contributed positively to equity growth.
- Dividend payments of 792,000,000 reduced retained earnings.
- Other factors increased equity by 951,000,000.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr2.36 Billion | +20.24% |
| Dividends Paid | Skr792.00 Million | -6.8% |
| Other Changes | Skr951.00 Million | +8.16% |
| Total Change | Skr- | 27.56% |
Book Value vs Market Value Analysis
This analysis compares HEXPOL AB ser. B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently HEXPOL AB ser. B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.24%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.73%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 1.54x
- Recent ROE (20.24%) is above the historical average (18.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 21.78% | 12.49% | 1.18x | 1.48x | Skr826.00 Million |
| 2018 | 19.16% | 11.95% | 0.95x | 1.68x | Skr786.80 Million |
| 2019 | 15.81% | 9.94% | 0.89x | 1.79x | Skr566.40 Million |
| 2020 | 15.43% | 10.50% | 0.89x | 1.65x | Skr495.70 Million |
| 2021 | 20.24% | 14.73% | 0.89x | 1.54x | Skr1.19 Billion |
Industry Comparison
This section compares HEXPOL AB ser. B's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HEXPOL AB ser. B (0R7O) | Skr11.65 Billion | 21.78% | 0.54x | $1.64 Billion |
| Nyfosa AB (0A0K) | $3.48 Billion | 34.90% | 2.92x | $966.63 Million |
| Tethys Oil AB (0A1V) | $56.23 Million | 21.07% | 0.01x | $122.95 Million |
| High Templar Tech Limited (0A2T) | $11.29 Billion | 0.81% | 0.10x | $258.25 Million |
| Strategy Inc (0A7O) | $361.50 Million | 1.39% | 0.55x | $38.08 Billion |
| NACON SASU (0A9N) | $210.72 Million | 8.63% | 0.51x | $7.82 Million |
| Antin Infrastructure Partners (0AA5) | $32.26 Million | 152.50% | 1.23x | $545.92 Million |
| Truecaller AB Series B (0AA7) | $1.51 Billion | 34.81% | 0.30x | $277.14 Million |
| Brockhaus Technologies AG (0AAW) | $315.34 Million | 15.55% | 1.46x | $74.17 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $-10.19 Million | 0.00% | 0.00x | $71.96 Million |
| Kalray S.A. (0ABT) | $39.07 Million | -59.55% | 1.26x | $33.84 Million |